Liminatus Pharma Inc. Class A Company Profile
NASDAQ: LIMNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Liminatus Pharma at a glance
Liminatus Pharma Inc. Class A (NASDAQ: LIMN) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Cerritos, CA. Liminatus Pharma is led by Mr. Chris Kim J.D., L.L.M. and employs about 1 people. At a market capitalization of $5.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001971387, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Liminatus Pharma do?
Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
Business description based on the company's public filings.
Company information
- Legal name
- Liminatus Pharma Inc. Class A
- Ticker
- NASDAQ: LIMN
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Chris Kim J.D., L.L.M.
- Employees
- 1
- Headquarters
- 12611 Hiddencreek Way, Cerritos, CA, United States
- Phone
- 213 273 5453
- Website
- liminatuspharma.com
- Market cap
- $4.96M
- SEC CIK
- 0001971387
- Latest annual report
- 10-K · Mar 31, 2026
Companies similar to Liminatus Pharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PMCBPharmaCyte Biotech Inc. | 0.4044 | +0.12% | $4.34M | vs LIMN |
| CLDICalidi Biotherapeutics Inc. | 1.03 | -0.96% | $3.79M | vs LIMN |
| CELZCreative Medical Technology Holdings Inc. | 0.8385 | -2.53% | $6.37M | vs LIMN |
| BTTCBlack Titan Corporation | 0.4759 | -3.86% | $6.52M | vs LIMN |
| SLXNSilexion Therapeutics Corp | 0.2146 | -8.64% | $3.11M | vs LIMN |
| VIVSVivoSim Labs Inc. | 0.1801 | +1.64% | $2.99M | vs LIMN |
| AIMAIM ImmunoTech Inc. | 0.18 | +0.22% | $7.18M | vs LIMN |
| HLSQTessera Defense and Homeland Security Inc. | 0.285 | -2.23% | $2.57M | vs LIMN |